TabsDetailsBasic DetailsDate Posted: Wednesday, February 28, 2018Status: CompleteMedical Product: axitinib, pazopanib, sorafenib, sunitinib, tyrosine kinase inhibitorDescription: These reports contain baseline characteristics of patients receiving four types of tyrosine kinase inhibitors (TKIs) in the Sentinel Distributed Database (SDD). This request was distributed to 16 Data Partners on August 23, 2016; this report contains data from 16 Data Partners. Read More Deliverables (3)Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 1Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 2Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 3Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2006 - September 30, 2015Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: Individuals 18 years of age or olderData Sources: Sentinel Distributed Database (SDD)
